NEOG
Price
$5.20
Change
+$0.28 (+5.69%)
Updated
Apr 24, 02:40 PM (EDT)
Capitalization
3.42B
96 days until earnings call
RVTY
Price
$94.19
Change
+$0.51 (+0.54%)
Updated
Apr 24, 02:47 PM (EDT)
Capitalization
12.76B
4 days until earnings call
Ad is loading...

NEOG vs RVTY

Header iconNEOG vs RVTY Comparison
Open Charts NEOG vs RVTYBanner chart's image
Neogen
Price$5.20
Change+$0.28 (+5.69%)
Volume$1.8K
Capitalization3.42B
Revvity
Price$94.19
Change+$0.51 (+0.54%)
Volume$500
Capitalization12.76B
NEOG vs RVTY Comparison Chart
Loading...
NEOG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEOG vs. RVTY commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEOG is a Hold and RVTY is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (NEOG: $4.91 vs. RVTY: $93.68)
Brand notoriety: NEOG and RVTY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NEOG: 111% vs. RVTY: 149%
Market capitalization -- NEOG: $3.42B vs. RVTY: $12.76B
NEOG [@Medical Specialties] is valued at $3.42B. RVTY’s [@Medical Specialties] market capitalization is $12.76B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEOG’s FA Score shows that 1 FA rating(s) are green whileRVTY’s FA Score has 0 green FA rating(s).

  • NEOG’s FA Score: 1 green, 4 red.
  • RVTY’s FA Score: 0 green, 5 red.
According to our system of comparison, NEOG is a better buy in the long-term than RVTY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEOG’s TA Score shows that 4 TA indicator(s) are bullish while RVTY’s TA Score has 5 bullish TA indicator(s).

  • NEOG’s TA Score: 4 bullish, 3 bearish.
  • RVTY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RVTY is a better buy in the short-term than NEOG.

Price Growth

NEOG (@Medical Specialties) experienced а +6.74% price change this week, while RVTY (@Medical Specialties) price change was -1.95% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.08%. For the same industry, the average monthly price growth was -6.75%, and the average quarterly price growth was -2.65%.

Reported Earning Dates

NEOG is expected to report earnings on Jul 29, 2025.

RVTY is expected to report earnings on Aug 04, 2025.

Industries' Descriptions

@Medical Specialties (+4.08% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVTY($12.8B) has a higher market cap than NEOG($3.42B). NEOG has higher P/E ratio than RVTY: NEOG (150.80) vs RVTY (71.72). RVTY YTD gains are higher at: -15.953 vs. NEOG (-59.555). RVTY has higher annual earnings (EBITDA): 714M vs. NEOG (189M). RVTY has more cash in the bank: 1.6B vs. NEOG (230M). NEOG has less debt than RVTY: NEOG (889M) vs RVTY (4.07B). RVTY has higher revenues than NEOG: RVTY (2.75B) vs NEOG (919M).
NEOGRVTYNEOG / RVTY
Capitalization3.42B12.8B27%
EBITDA189M714M26%
Gain YTD-59.555-15.953373%
P/E Ratio150.8071.72210%
Revenue919M2.75B33%
Total Cash230M1.6B14%
Total Debt889M4.07B22%
FUNDAMENTALS RATINGS
NEOG vs RVTY: Fundamental Ratings
NEOG
RVTY
OUTLOOK RATING
1..100
575
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
65
Fair valued
PROFIT vs RISK RATING
1..100
10080
SMR RATING
1..100
9285
PRICE GROWTH RATING
1..100
9764
P/E GROWTH RATING
1..100
290
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RVTY's Valuation (65) in the Medical Specialties industry is in the same range as NEOG (96). This means that RVTY’s stock grew similarly to NEOG’s over the last 12 months.

RVTY's Profit vs Risk Rating (80) in the Medical Specialties industry is in the same range as NEOG (100). This means that RVTY’s stock grew similarly to NEOG’s over the last 12 months.

RVTY's SMR Rating (85) in the Medical Specialties industry is in the same range as NEOG (92). This means that RVTY’s stock grew similarly to NEOG’s over the last 12 months.

RVTY's Price Growth Rating (64) in the Medical Specialties industry is somewhat better than the same rating for NEOG (97). This means that RVTY’s stock grew somewhat faster than NEOG’s over the last 12 months.

NEOG's P/E Growth Rating (2) in the Medical Specialties industry is significantly better than the same rating for RVTY (90). This means that NEOG’s stock grew significantly faster than RVTY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NEOGRVTY
RSI
ODDS (%)
Bullish Trend 2 days ago
47%
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 4 days ago
65%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
69%
Declines
ODDS (%)
Bearish Trend 8 days ago
77%
Bearish Trend 4 days ago
65%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 2 days ago
66%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
64%
View a ticker or compare two or three
Ad is loading...
NEOG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FHCCX36.45N/A
N/A
Fidelity Advisor Health Care C
GSGRX43.68N/A
N/A
Goldman Sachs Equity Income A
VDIPX25.83N/A
N/A
Vanguard Developed Markets Index Ins Pls
RMLPX23.20N/A
N/A
Recurrent MLP & Infrastructure Class I
FLOWX17.24N/A
N/A
Fidelity Water Sustainability

NEOG and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEOG has been loosely correlated with RVTY. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if NEOG jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEOG
1D Price
Change %
NEOG100%
+3.37%
RVTY - NEOG
42%
Loosely correlated
+1.46%
IQV - NEOG
40%
Loosely correlated
+2.40%
CNMD - NEOG
40%
Loosely correlated
+3.52%
SHC - NEOG
39%
Loosely correlated
+2.16%
RDNT - NEOG
38%
Loosely correlated
+1.74%
More

RVTY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVTY has been closely correlated with IQV. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if RVTY jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVTY
1D Price
Change %
RVTY100%
+1.46%
IQV - RVTY
66%
Closely correlated
+2.40%
CRL - RVTY
63%
Loosely correlated
+1.97%
A - RVTY
62%
Loosely correlated
+2.13%
TMO - RVTY
62%
Loosely correlated
-0.71%
BIO - RVTY
60%
Loosely correlated
+1.58%
More